pmid,title,journal,year,drug,disease
37265903,Fulminant Clostridioides difficile Colitis With SARS-CoV-2 Infection.,Cureus,2023,Baricitinib,Parkinson's
35908569,"Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.","Lancet (London, England)",2022,Baricitinib,Parkinson's
